title: [Effect of early allergen immunization on the development of allergic rhinitis in mouse].
abstract: OBJECTIVE
  To investigate the effect of early allergen exposure on later development of allergic rhinitis in mouse.
  
  
  METHODS
  Twenty-four BALB/c neonates were randomly divided into 4 groups (low-dose group, high-dose group, negative control group and positive control group), each group had 6 mice. The mice were administered ovalbumin (OVA) by subcutaneous injection on day 1, 5, 12 after birth (10 μg OVA in 0.05 ml saline for low-dose group, 1000 μg OVA in 0.05 ml saline for high-dose group, only saline for negative and positive control group). Then the mice were sensitized and intranasally challenged with OVA (saline without OVA was used in negative control group) after 6 weeks. Symptoms, histopathological changes of nasal mucosa were observed, OVA-IgE in serum was examined, cytokines IL-4, IL-5 and IFN-gamma were detected in the supernatant of cultured splenic mononuclear cells.
  
  
  RESULTS
  Compared to the positive control group, symptoms and nasal mucosa histological changes of high-dose group was indistinctive. The level of OVA-IgE and cytokines IL-4, IL-5 (x(-) +/- s) in high-dose group [(265.11 +/- 26.29), (446.39 +/- 72.83) and (171.24 +/- 15.66) pg/ml, respectively] were significantly lower than those in positive control group [(665.85 +/- 43.15), (1113.45 +/- 30.47), (255.36 +/- 30.96) pg/ml, respectively, t value were 0.000, 0.000 and 0.009, respectively, all P < 0.05]. The level of IFN-γ in high-dose group [(319.74 +/- 56.30) pg/ml] was significantly higher than those in positive control group [(170.02 +/- 14.50) pg/ml, t = 0.000, P < 0.05]. There was no significant difference of the results between the low-dose group and positive control group.
  
  
  CONCLUSIONS
  Neonatal immunization with high-dose OVA inhibited the future allergic rhinitis symptoms, nasal histological changes, serum OVA-IgE levels and Th1/Th2 cytokine imbalance, resulting in the protective effect.
authors.affiliation: Department of Otorhinolaryngology, Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhou
authors.forename: Jian-jun
authors.initials: JJ
authors.lastname: Chen
authors.forename: Zhong-yuan
authors.initials: ZY
authors.lastname: Lu
authors.forename: Wei-jia
authors.initials: WJ
authors.lastname: Kong
mesh_terms: D000485:Allergens / Q000276:immunology*; D000818:Animals; D000831:Animals, Newborn; D004306:Dose-Response Relationship, Immunologic; D007073:Immunoglobulin E / Q000097:blood; D007371:Interferon-gamma / Q000032:analysis; D015847:Interleukin-4 / Q000032:analysis; D015848:Interleukin-5 / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D009297:Nasal Mucosa / Q000276:immunology; D009299:Nasal Provocation Tests; D010047:Ovalbumin / Q000276:immunology*; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology* / Q000517:prevention & control
chemical_list: D000485:Allergens; D015848:Interleukin-5; D015847:Interleukin-4; D007073:Immunoglobulin E; D007371:Interferon-gamma; D010047:Ovalbumin